Etodolac

etodolaco

BrazilAuthorisedAuthorised 11 May 2026

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Etodolac

etodolaco

BrazilAuthorisedAuthorised 11 May 2026

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Etodolac
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 11 May 2026
Registration: 104971571
Marketing authorisation holder: União Química Farmacêutica Nacional S/A
Procedure: Registered

Anvisa

DueforziEtodolacBrazil

EtodEtodolacBrazil

etodolacoEtodolacBrazil